Space investing: Europe’s growing space sector

Raghav Mittal, Assistant Director, Acuity Knowledge Partners’ recently spoke to Investors.com, a platform for individual and professional investors. He speaks about the growing trend of large pharmaceutical companies acquiring smaller biotech companies with promising oncology or immunology programs.

‘Acquisitions of biotech companies working on oncology or immunology treatments could be worth $5 billion to $25 billion a pop’, he explains.